Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Natural Organics

This article was originally published in The Tan Sheet

Executive Summary

Supplement marketer barred from claiming Pedi-Active A.D.D. or any other supplement, food or drug improves children's attention span and scholastic performance and treats or mitigates attention deficit/hyperactivity disorder in children "absent competent and reliable scientific evidence," according to FTC consent agreement released July 31. Melville, N.Y.-based firm also prohibited from using term "A.D.D." as representing treatment for ADHD. Agreement subject to public comment until Aug. 30, after which it could become final. In August 2000, FTC challenged Natural Organics' Pedi-Active claims on ads, brochures, letters and its Web site (1"The Tan Sheet" Aug. 21, p. 7)
Advertisement

Related Content

Natural Organics ADHD Claims Prohibited Under FTC Complaint
Natural Organics ADHD Claims Prohibited Under FTC Complaint

Topics

Advertisement
UsernamePublicRestriction

Register

PS092877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel